Insider: Korenberg Matthew E President & COO - LIGAND PHARMACEUTICALS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 50,777 | 0 | 50,777 |
| Value | $10,134,581.43 | $0.00 | $10,134,581.43 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/23/2024 | DDS | 201 | Direct | COM | $102.05 | $20,512.87 | 50,777 |
| 09/23/2024 | DDS | 2,481 | Direct | COM | $100.05 | $248,228.27 | 58,068 |
| 09/23/2024 | DDS | 7,090 | Direct | COM | $101.61 | $720,379.45 | 50,978 |
| 09/20/2024 | DDS | 6,275 | Direct | COM | $104.10 | $653,238.17 | 50,777 |
| 08/26/2024 | DDS | 6,177 | Direct | COM | $105.02 | $648,683.83 | 54,722 |
| 08/26/2024 | DDS | 5,212 | Direct | COM | $106.32 | $554,147.14 | 49,510 |
| 08/23/2024 | DDS | 2,037 | Direct | COM | $104.09 | $212,040.50 | 65,174 |
| 08/23/2024 | DDS | 4,275 | Direct | COM | $105.13 | $449,438.87 | 60,899 |
| 08/22/2024 | DDS | 1,157 | Direct | COM | $105.54 | $122,109.78 | 67,211 |
| 08/09/2024 | DDS | 18,245 | Direct | COM | $98.50 | $1,797,132.50 | 68,368 |
| 05/14/2024 | DDS | 13,638 | Direct | COM | $85.08 | $1,160,356.50 | 86,783 |
| 05/14/2024 | DDS | 520 | Direct | COM | $85.68 | $44,555.73 | 86,263 |
| 05/13/2024 | DDS | 3,440 | Direct | COM | $84.54 | $290,828.26 | 100,421 |
| 09/03/2019 | AAP | 500 | Direct | COM | $86.18 | $43,090.75 | 17,151 |
| 08/29/2018 | DDS | 18,357 | Direct | COM | $256.69 | $4,712,060.17 | 6,742 |
| 11/17/2017 | DDS | 6,559 | Direct | COM | $142.63 | $935,510.17 | 8,147 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research